# NIH Reporter #1P50HD123367-01

In vitro, ex vivo and in vivo Efficacy Core

**Recipient:** Weill Medical College of Cornell University

**Award Amount:** $420,951.00
**Ceiling:** $420,951.00

**Awarded:** September 10, 2026

**Identifier:** 1P50HD123367-01

The award funds the development of assays to test the efficacy of sAC inhibitors for male contraception, supporting progression to clinical trials.

### Description

This grant supports the development of assays to evaluate the efficacy of soluble adenylyl cyclase inhibitors as male contraceptives, aiming to progress into first-in-human trials.

[View original record](https://reporter.nih.gov/search/0C83gI3MXki4-tEhFD4UKQ/project-details/11451841)